Blood and Marrow Transplantation (BMT)/Immunotherapy Fellow

Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Hematology and Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.

This is a year-long fellowship program with the goal of becoming an expert in BMT and immunotherapy. Rotations will include outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up, etc.) and immunotherapy services. The fellow will initially function as a primary provider with direct patient care responsibilities and will have increasing levels of clinical team leadership over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available for clinically focused research projects. 

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.

At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.

Anticipated start date: July 1, 2025

​

Qualifications

The ideal candidate should have a career interest in hematopoietic cell transplantation and/or immunotherapy and should have completed a fellowship in hematology or hematology­-oncology (or foreign equivalent).

Applicants must have an MD/DO degree (or foreign equivalent) and be American Board of Internal Medicine (ABIM) eligible or certified in Medical Oncology or Hematology (or foreign equivalent). In order to be eligible for University sponsorship for an H-1 B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE), or equivalent as determined by the Secretary of Health and Human Services.